TY - CONF
TI - Sustained minimal residual disease (MRD) negativity and clinical efficacy in transplant-ineligible (TIE) newly diagnosed multiple myeloma (NDMM) patients (Pts) treated with daratumumab-based regimens: analysis of MAIA and Alcyone
AU - San-Miguel, Jesus F
AU - Avet-Loiseau, Herve
AU - Paiva, Bruno
AU - Kumar, Shaji K
AU - Dimopoulos, Meletios A
AU - Facon, Thierry
AU - Mateos, Maria-Victoria
AU - Touzeau, Cyrille
AU - Jakubowiak, Andrzej
AU - Usmani, Saad Z
AU - others
PY - 2020
SP - null
PB - 
T2 - Blood
TODO - null
TODO - null
TODO - null
ER -